Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT04899674 Completed - Healthy Clinical Trials

A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood

Start date: June 30, 2021
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the relative bioavailability of a single dose of bupropion when given alone (Reference) compared with co-administration (Test) with BI 1358894 in healthy volunteers.

NCT ID: NCT04899219 Completed - Healthy Clinical Trials

A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

Start date: June 16, 2021
Phase: Phase 1
Study type: Interventional

An open-label, single-dose study to investigate the pharmacokinetics of ACT-1014-6470 in subjects with severe renal impairment compared to control subjects

NCT ID: NCT04899193 Completed - Healthy Clinical Trials

Pergoveris FD and Liquid China BE Study

Start date: May 8, 2021
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to assess the bioequivalence (BE) of the fixed combination of follitropin alfa and lutropin alfa in Pergoveris freeze-dried (FD) (Test 1) or in Pergoveris Liquid (Test 2) versus the co-administration of Gonal-f and Luveris (Reference), administered subcutaneously (SC) in pituitary suppressed, healthy premenopausal Chinese female participants, at the doses of 900 international unit (IU) of follitropin alfa and 450 IU lutropin alfa.

NCT ID: NCT04898660 Completed - Healthy Clinical Trials

The Embedded Participant During High-fidelity Simulation

Start date: September 1, 2021
Phase:
Study type: Observational

Simulation in medicine is a powerful and effective teaching tool that has become essential for the training of students and health professionals. In this context, simulation instructor training have been implemented in recent years, where many subjects are addressed, such as the main principles of pedagogy, the integration of simulation, the construction of a scenario, briefing and debriefing. However, scenario facilitation, in particular the role of the embedded participant (EP), is only vaguely discussed. The EP of a high-fidelity simulation session plays a very important role in driving the scenario. Indeed, he/she guides the learner in order to achieve all the educational objectives set by the main instructor of the scenario. He/she also manages unexpected behavior and possible technical issues that may arise. Finally, the EP supervises the physical and psychological risks inherent in the simulation in order to maintain a safe environment. All of these key roles suggest that the EP can influence the performance of the learners. Little is known about the relationship between Facilitation and Learner Performance. In this observational study, investigators aim to explore the influence of the embedded participant on learners' technical and non-technical performances during high-fidelity simulation by analysing previously recorded sessions.

NCT ID: NCT04895059 Completed - Healthy Clinical Trials

Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components

Start date: April 30, 2017
Phase: Phase 1
Study type: Interventional

Monocentric study of no pharmacokinetic interaction between rosuvastatin 20 mg and ezetimibe 10 mg. An open design, randomized, single dose with three periods, six sequences and crossed, in healthy volunteers with fasting conditions, managed in fixed dose combination (Sponsor Laboratorios Silanes S.A. de C.V.) versus individual components managed by separated (Crestor®, product of Astrazeneca, S.A. de C.V and Ezetrol®. product of Undra S.A. de C.V.)

NCT ID: NCT04894305 Completed - Healthy Clinical Trials

A Study of Ad26.COV2.S in Healthy Adults (COVID-19)

Start date: May 25, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and reactogenicity of Ad26.COV2.S (0.3 milliliter [mL] versus 0.5 mL) and to demonstrate non-inferiority (NI) of Ad26.COV2.S (0.3 mL versus 0.5 mL), 28 days after vaccination.

NCT ID: NCT04891393 Completed - Healthy Clinical Trials

The Effects of Caffeine on Human Spinal Motoneurons

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study evaluates the effects of orally ingested, commercially available, coffee (3 mg/kg of caffeine) on the excitability of human spinal motoneurons of the lower leg.

NCT ID: NCT04891120 Completed - Healthy Clinical Trials

Treadmill Stress Test With and Without Mask

TREADMASK
Start date: May 11, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess if wearing a surgical mask affects the results of a standard treadmill test.

NCT ID: NCT04890470 Completed - Healthy Clinical Trials

Effects of Oxytocin and Vasopressin on Moral Decision Making

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making

NCT ID: NCT04889690 Completed - Healthy Clinical Trials

Study of Multiple Doses of Danicopan in Healthy Participants

Start date: May 21, 2016
Phase: Phase 1
Study type: Interventional

This was a multiple ascending dose, randomized, double-blind study assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of danicopan in healthy participants. Four different doses (75 milligrams [mg], 200 mg, 500 mg, 800 mg) and dose-matched placebo were administered under fasted conditions.